Safety and efficacy of low dose naltrexone in a long covid cohort; an interventional pre-post study.

September 8, 2024 | John Murphy | Leave a Comment

Safety and efficacy of low dose naltrexone in a long covid cohort; an interventional pre-post study.

O'Kelly B 1,2, Vidal L 2, McHugh T 2, et. al. Brain, Behavior, & Immunity - Health, 03 Jul 2022, 24:100485, https://doi.org/10.1016/j.bbih.2022.100485 PMID: 35814187 PMCID: PMC9250701 Abstract Background Up to 37.7% of patients experience symptoms beyond 12 weeks after…[...]

September 8, 2024 | John Murphy | Leave a Comment

POST-ACUTE SEQUELAE OF COVID-19: CHARACTERIZATION, COMORBIDITIES, AND BIOMARKERS IN A DIVERSE COHORT

Emily Struttmann, Anish Shah, Matthew Moreida, et. al. doi: https://doi.org/10.1101/2024.06.20.24308901 Abstract Introduction Post-acute sequelae of COVID-19 (PASC) is causing a silent pandemic in the U.S. Gulf South, a part of flyover U.S. where patients are quietly withdrawing…[...]

September 6, 2024 | John Murphy | Leave a Comment

Patients with neurological disease are likelier to die after COVID, finds study

by Geoff McMaster, University of Alberta People with neurological disease have a greater chance of death after contracting COVID-19, according to a new University of Alberta study. The research also confirms…[...]

September 4, 2024 | John Murphy | Leave a Comment

Two studies unveil key insights into long COVID

by University of Texas at Austin Health care providers are learning critical new information to help improve care for patients with long COVID, thanks to a pair of recent studies out…[...]

August 30, 2024 | John Murphy | Leave a Comment

Could COVID-19 Be Causing This Rare Spinal Cord Disorder?

Can COVID-19 cause a rare spinal condition called transverse myelitis? Learn what TM is and see the evidence connecting the two conditions. The year 2020 has been one for the…[...]

August 24, 2024 | John Murphy | Leave a Comment

How wave of new dementias may be fueled by surprising culprit every home has been touched by

By Maiya Focht, A new study has added fuel to concerns that America could face a surge in dementias in coming years and decades due to COVID. The research found that…[...]

August 24, 2024 | John Murphy | Leave a Comment

Two-Year Longitudinal Study Reveals That Long COVID Symptoms Peak and Quality of Life Nadirs at 6–12 Months Postinfection

Zoe O Demko, Tong Yu, Sarika K Mullapudi, et. al., Open Forum Infectious Diseases, Volume 11, Issue 3, March 2024, ofae027, https://doi.org/10.1093/ofid/ofae027 Abstract Background Few longitudinal studies available characterize long COVID outcomes out to…[...]

August 22, 2024 | John Murphy | Leave a Comment

Sleep and Long COVID—A Review and Exploration of Sleep Disturbances in Post Acute Sequelae of SARS-COV-2 (PASC) and Therapeutic Possibilities

Volume 10, pages 169–180, (2024), Elliott K Lee & R. Robert Auger Abstract Purpose of Review Post Acute Sequelae of Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-COV-2), also known as PASC, and frequently referred to…[...]

August 22, 2024 | John Murphy | Leave a Comment

The knowns and unknowns of long COVID-19: from mechanisms to therapeutical approaches

Roxana Gheorghita1,2Iuliana Soldanescu3Andrei Lobiuc2 , et. al., Front. Immunol., 03 March 2024, Sec. Viral Immunology, Volume 15 - 2024 | https://doi.org/10.3389/fimmu.2024.1344086 The coronavirus disease 2019 (COVID-19) pandemic caused by SARS-CoV-2 has…[...]

August 21, 2024 | John Murphy | Leave a Comment

Pathophysiological, immunological, and inflammatory features of long COVID

Karen Bohmwald1,2†Benjamín Diethelm-Varela1†Linmar Rodríguez-Guilarte1 , et. al., Front. Immunol., 27 February 2024, Sec. Viral Immunology, Volume 15 - 2024 | https://doi.org/10.3389/fimmu.2024.1341600 The COVID-19 pandemic continues to cause severe global disruption, resulting…[...]